On Monday, ANI Pharmaceuticals Inc (NASDAQ: ANIP) opened lower -2.57% from the last session, before settling in for the closing price of $82.85. Price fluctuations for ANIP have ranged from $52.74 to $99.50 over the past 52 weeks.
Company’s average yearly earnings per share was noted 44.69% at the time writing. With a float of $19.25 million, this company’s outstanding shares have now reached $22.46 million.
ANI Pharmaceuticals Inc (ANIP) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of ANI Pharmaceuticals Inc is 14.31%, while institutional ownership is 92.12%. The most recent insider transaction that took place on Dec 18 ’25, was worth 133,653. In this transaction SVP, CHIEF HR OFFICER of this company sold 1,622 shares at a rate of $82.40, taking the stock ownership to the 58,564 shares. Before that another transaction happened on Dec 12 ’25, when Company’s SR. VP, GENERAL COUNSEL & SEC. sold 400 for $82.32, making the entire transaction worth $32,928. This insider now owns 74,874 shares in total.
ANI Pharmaceuticals Inc (ANIP) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 1.63 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 1.43) by 0.19. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.69% per share during the next fiscal year.
ANI Pharmaceuticals Inc (NASDAQ: ANIP) Trading Performance Indicators
Check out the current performance indicators for ANI Pharmaceuticals Inc (ANIP). In the past quarter, the stock posted a quick ratio of 2.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.19. Likewise, its price to free cash flow for the trailing twelve months is 11.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.63, a number that is poised to hit 1.98 in the next quarter and is forecasted to reach 8.53 in one year’s time.
Technical Analysis of ANI Pharmaceuticals Inc (ANIP)
The latest stats from [ANI Pharmaceuticals Inc, ANIP] show that its last 5-days average volume of 0.51 million was superior to 0.38 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.35%.
During the past 100 days, ANI Pharmaceuticals Inc’s (ANIP) raw stochastic average was set at 49.00%, which indicates a significant increase from 37.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.33 in the past 14 days, which was lower than the 2.91 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $86.63, while its 200-day Moving Average is $76.72. Now, the first resistance to watch is $83.40. This is followed by the second major resistance level at $86.08. The third major resistance level sits at $88.50. If the price goes on to break the first support level at $78.29, it is likely to go to the next support level at $75.87. The third support level lies at $73.19 if the price breaches the second support level.
ANI Pharmaceuticals Inc (NASDAQ: ANIP) Key Stats
There are currently 22,469K shares outstanding in the company with a market cap of 1.81 billion. Presently, the company’s annual sales total 614,380 K according to its annual income of -18,520 K. Last quarter, the company’s sales amounted to 227,810 K and its income totaled 26,620 K.
